awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44485413-68D2B7BA-AE06-4D4C-82FC-1022FEBF2C62
Q44485413-68D2B7BA-AE06-4D4C-82FC-1022FEBF2C62
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44485413-68D2B7BA-AE06-4D4C-82FC-1022FEBF2C62
Information contributed by meta-analysis in exposure-response modeling: application to phase 2 dose selection of guselkumab in patients with moderate-to-severe psoriasis.
P2860
Q44485413-68D2B7BA-AE06-4D4C-82FC-1022FEBF2C62
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44485413-68D2B7BA-AE06-4D4C-82FC-1022FEBF2C62
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fa0003c11a58b9abb37e8ded9491802b7c46414c
P2860
Informative dropout modeling of longitudinal ordered categorical data and model validation: application to exposure-response modeling of physician's global assessment score for ustekinumab in patients with psoriasis.